Treatment of osteoporosis combined with a bisphosphonate and vitamin D3
Kobayashi, S.; Shiraki, M.; Takaoka, K.
Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 2): 461-465
2004
ISSN/ISBN: 0047-1852 PMID: 15035171 Document Number: 580923
Document emailed within 1 workday
Related Documents
Keen, R.W.; Spector, T.D. 1996: Alendronate: a new bisphosphonate for the treatment of osteoporosis British Journal of Clinical Practice 50(4): 211-217Miki, T. 2017: Efficacy and safety of long-term bisphosphonate treatment for osteoporosis Clinical Calcium 27(2): 239-246
Rossini, M.; Di Munno, O.; Gatti, D.; Giannini, S.; Minisola, S.; Varenna, M.; Adami, S. 2011: Optimising bisphosphonate treatment outcomes in postmenopausal osteoporosis: review and Italian experience Clinical and Experimental Rheumatology 29(4): 728-735
Scharla, S.H. 1999: Therapy of osteoporosis: native vitamin D or as hormone? Advantages of activated vitamin D in secondary osteoporosis MMW Fortschritte der Medizin 141(31-32): 32-36
Wang, Q.; Zhang, Y.; Gao, L.; Xue, Y. 2011: Effects of phytoestrogen, genistein combined with calcium and vitamin D3 on preventing osteoporosis in ovariectomized mice Wei Sheng Yan Jiu 40(5): 587-590
Urade, M. 2009: New development in bisphosphonate treatment. Bisphosphonate therapy and osteonecrosis of the jaws Clinical Calcium 19(1): 100-108
Papapoulos, S.E. 2003: Ibandronate: a potent new bisphosphonate in the management of postmenopausal osteoporosis International Journal of Clinical Practice 57(5): 417-422
Koval, P.G.; Easterling, L.; Pettus, D.; Mackler, L.; Gottschall, A.B. 2005: Clinical inquiries. how should a DEXA scan be used to evaluate bisphosphonate therapy for osteoporosis? Journal of Family Practice 54(1): 65; 69-71
Ijiri, S. 2008: Patient's preference for the daily and weekly bisphosphonate--evaluation from questionnaire of osteoporosis patients Nihon Rinsho. Japanese Journal of Clinical Medicine 66(1): 205-211
Gallagher, J.C. 1996: The role of vitamin D in the pathogenesis and treatment of osteoporosis Journal of Rheumatology. Suppl 45: 15-18
Briancon, D.; Meunier, P.J. 1981: Treatment of osteoporosis with fluoride, calcium, and vitamin D Orthopedic Clinics of North America 12(3): 629-648
Hokugo, A. 2012: Vitamin D and bisphosphonate-related osteonecrosis of the jaw (BRONJ) Clinical Calcium 22(1): 83-90
Grana, J.; Mahia, I.V.; Meizoso, M.-O.S.; Vazquez, T. 2008: Multiple osteonecrosis of the jaw, oral bisphosphonate therapy and refractory rheumatoid arthritis (Pathological fracture associated with ONJ and BP use for osteoporosis) Clinical and Experimental Rheumatology 26(2): 384-385
Hasling, C.; Nielsen, H.E.; Melsen, F.; Mosekilde, L. 1987: Safety of osteoporosis treatment with sodium fluoride, calcium phosphate and vitamin D Mineral and Electrolyte Metabolism 13(2): 96-103
Loddenkemper, K.; Grauer, A.; Burmester, G.R.; Buttgereit, F. 2003: Calcium, vitamin D and etidronate for the prevention and treatment of corticosteroid-induced osteoporosis in patients with rheumatic diseases Clinical and Experimental Rheumatology 21(1): 19-26
Kamalova, N.A. 2011: Certain changes in mineral metabolism of patients with osteoarthrosis and osteoporosis under the influence of combined treatment Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 2: 16-18
Simonin, R.; Nicolino-Peltier, C.; Gainlet, P. 1989: Gonadorelin analogs combined with anti-androgens in the treatment of bone metastasis from prostate cancer. can their use induce osteoporosis? Presse Medicale 18(41): 2023
Scal, J.C. 1956: Epistaxis; treatment with a new citrus flavinoid compound combined with vitamin K Eye Ear Nose and Throat Monthly 35(11): 719-721
Kunin, N.A. 1988: Treatment of severe forms of acne by combined administration of Roaccutan and vitamin e Vestnik Dermatologii i Venerologii 1: 48-50
Samoĭlovich, V.A. 1989: The use of vitamin preparations in the combined treatment of periodontal diseases and their side effects Fel'dsher i Akusherka 54(7): 43-45